HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

HuM195 antibody

a humanized anti-CD33 antibody (HuM195) in patients with relapsed or refractory acute myeloid leukemia
Also Known As:
SGN-33; Zamyl; lintuzumab
Networked: 11 relevant articles (2 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Jurcic, Joseph G: 4 articles (01/2014 - 08/2009)
2. Sievers, Eric L: 4 articles (01/2013 - 08/2009)
3. Rosenblat, Todd L: 2 articles (01/2014 - 11/2010)
4. Wood, Brent L: 2 articles (01/2013 - 08/2009)
5. Grove, Laurie E: 2 articles (01/2013 - 08/2009)
6. Yu, Changpu: 2 articles (07/2010 - 09/2009)
7. Grewal, Iqbal S: 2 articles (07/2010 - 09/2009)
8. Sutherland, May Kung: 2 articles (07/2010 - 09/2009)
9. Law, Che-Leung: 2 articles (07/2010 - 09/2009)
10. Roboz, Gail J: 2 articles (08/2009 - 06/2005)

Related Diseases

1. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
2. Neoplasms (Cancer)
3. Chills
4. Residual Neoplasm
5. Acute Promyelocytic Leukemia

Related Drugs and Biologics

1. Azacitidine (5 Azacytidine)
2. Cytarabine (Cytosar-U)
3. Surface Antigens (Surface Antigen)
4. Sirolimus (Rapamycin)
5. Simvastatin (Zocor)
6. Ritonavir (Norvir)
7. Lamivudine (3TC)
8. Enoxaparin (Lovenox)
9. Amlodipine (Norvasc)
10. Interferon Alfa-2b (Interferon Alfa 2b)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Heterologous Transplantation (Xenotransplantation)
3. Immunotherapy
4. Stents
5. Aftercare (After-Treatment)